Title : EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.

Pub. Date : 2022 Jun

PMID : 35445730






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EGFR inhibition reverses epithelial-mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells. Tamoxifen epidermal growth factor receptor Homo sapiens
2 In addition, it was observed that the inhibition of epidermal growth factor receptor (EGFR) reversed the EMT phenotype in tamoxifen-resistant MCF7 (MCF-7/TR) cells via the downregulation of Snail and Twist. Tamoxifen epidermal growth factor receptor Homo sapiens
3 In addition, it was observed that the inhibition of epidermal growth factor receptor (EGFR) reversed the EMT phenotype in tamoxifen-resistant MCF7 (MCF-7/TR) cells via the downregulation of Snail and Twist. Tamoxifen epidermal growth factor receptor Homo sapiens
4 Notably, the EGFR inhibitor, gefitinib, decreased tamoxifen resistance, migration and invasion through the inhibition of Snail and Twist. Tamoxifen epidermal growth factor receptor Homo sapiens
5 On the whole, the results of the present study suggest that EGFR may be a promising therapeutic target for tamoxifen-resistant breast cancer. Tamoxifen epidermal growth factor receptor Homo sapiens